NORDHEALTH |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32.9 NOK | +5.45% |
|
+13.45% | +32.66% |
| Mar. 05 | Transcript : Nordhealth AS, Q4 2023 Earnings Call, Mar 05, 2024 | |
| Mar. 05 | Nordhealth AS Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 44.94M 48.28M 529M | Sales 2025 * | 53.23M 57.18M 626M | Capitalization | 210M 226M 2.48B |
|---|---|---|---|---|---|
| Net income 2024 * | -7M -7.52M -82.33M | Net income 2025 * | -1M -1.07M -11.76M | EV / Sales 2024 * | 4.13 x |
| Net cash position 2024 * | 24.7M 26.53M 291M | Net cash position 2025 * | 29.22M 31.39M 344M | EV / Sales 2025 * | 3.41 x |
| P/E ratio 2024 * |
-26.6
x | P/E ratio 2025 * |
-133
x | Employees | 385 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 46.53% |
More Fundamentals
* Assessed data
More news
Latest transcript on Nordhealth
| 1 day | +5.76% | ||
| 1 week | -4.59% | ||
| Current month | -4.59% | ||
| 1 month | +0.65% | ||
| 3 months | +17.74% | ||
| 6 months | +25.81% | ||
| Current year | +25.81% |
1 week
29.00
32.00
1 month
29.0038.00
Current year
23.6038.00
1 year
19.8038.00
3 years
15.2047.99
5 years
15.2047.99
10 years
15.2047.99
| Managers | Title | Age | Since |
|---|---|---|---|
| Founder | - | 00-12-31 | |
| Chief Executive Officer | - | 17-12-31 | |
| Director of Finance/CFO | - | 22-01-02 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Didier Breton
CHM | Chairman | 71 | 20-12-31 |
Philippe Vimard
BRD | Director/Board Member | 50 | 23-04-23 |
| Founder | - | 00-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-08 | 32.9 | +5.45% | 3 445 |
| 24-05-07 | 31.2 | +5.76% | 100,003 |
| 24-05-06 | 29.5 | +1.37% | 2,795 |
| 24-05-03 | 29.1 | +0.34% | 1 |
| 24-05-02 | 29 | -11.31% | 13,011 |
Real-time Oslo Bors, May 07, 2024 at 10:45 am EDT
More quotes
Nordhealth AS is a Norway-based cloud-based healthcare Software-as-a-Service business. The Company's flagship products are Provet Cloud and Diarium, both cloud-based Practice Management Software for veterinarians and therapists, respectively. The Group serves over 7,000 clinics and hospitals located in over 25 countries. Nordhealth's mission is to build software that empowers healthcare professionals to improve patient care, increase efficiency and expand their business.
Calendar
2024-05-15
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
2.663
EUR
Average target price
2.581
EUR
Spread / Average Target
-3.07%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +25.81% | 227M | |
| +6.64% | 33.18B | |
| +21.35% | 7.81B | |
| +23.82% | 3.98B | |
| -16.41% | 3.17B | |
| -19.48% | 1.39B | |
| -30.77% | 1.2B | |
| +8.47% | 970M | |
| -32.21% | 950M | |
| -28.36% | 808M |
- Stock Market
- Equities
- NORDH Stock